Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

Research and Innovation Action · Running

Re-MEND Building REsilience against MEntal illness during ENDocrine-sensitive life stages

Coordinator
Uppsala Universitet, Sweden
Runs
1 January 2023 to 31 December 2027
Status
Running
EU funding
€10.9m
Total cost
€10.9m
Partners
18 organisations in 8 countries
Type
Research and Innovation Action
Grant agreement
101057604

What the project is doing

In the project's own words, from its summary on CORDIS.

Mental illnesses represent a huge burden for society, the economy, and the aMental illnesses represent a huge burden for society, the economy, and the affected individuals. To significantly increase citizens? mental health, today?s symptom-based diagnoses need to be complemented by biological criteria accounting for individual and sex differences. Furthermore, early detection and prevention measures need to be improved.

RE-MEND addresses the current gaps and challenges with an interdisciplinary approach by: i) focussing on four critical life stages in which an individual?s susceptibility to mental illness is strongly influenced by changes in endocrine signalling, including sex hormones, namely early life, puberty, peripartum, and transition into old age; ii) integrating data from large population-based longitudinal cohort studies allowing for discovery of risk and protective factors as well as biological patterns that influence mental states in the general population across these life stages; iii) complementing epidemiological with experimental studies to establish correlative and causative links leading to mechanistic understanding; iv) using advanced biostatistics as well as machine learning and artificial intelligence for data integration and biomarker and drug target discovery; v) combining the biological approaches with communication science studies to efficiently translate its results to societal impact.

Ultemately, RE-MEND will result in: i) Significantly increased mental health literacy among stakeholders and citizens; ii) Validated biomarkers for assessing mental health state and its predisposition as well as more accurate diagnoses and personalised preventive and therapeutic measures; iii) Recommendations for early detection, better prevention, and drug design strategies to protect vulnerable individuals from mental illness in sensitive life stages; and iv) strategies on how these advances can be used to decrease stigma and increase prevention behaviour.

Topics

Who is involved

OrganisationCityCountryRole
Uppsala UniversitetUppsalaSwedenCoordinator
International Centre for Diarrhoeal Disease Research BangladeshDhakaBDParticipant
Klinikum Der Universitaet Zu KoelnKoelnGermanyParticipant
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyParticipant
Universitaet BielefeldBielefeldGermanyParticipant
Helsingin YliopistoHelsinkiFinlandParticipant
Fondazione Human TechnopoleMilanoItalyThird party
Fondazione Telethon EtsRomaItalyParticipant
Universita Degli Studi Di MilanoMilanoItalyParticipant
Universidade De AveiroAveiroPortugalParticipant
Karlstads UniversitetKarlstadSwedenParticipant
Karolinska InstitutetStockholmSwedenParticipant
Stockholms UniversitetStockholmSwedenParticipant
Umea UniversitetUmeaSwedenParticipant
Vetenskap & Allmanhet, VaStockholmSwedenParticipant
University of UlsterColeraineUnited KingdomAssociatedpartner
Icahn School of Medicine at Mount SinaiNew YorkUnited StatesParticipant
University of RochesterRochester NyUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI